Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up - Concepedia

Concepedia

Publication | Closed Access

Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up

32

Citations

16

References

2016

Year

João Paulo Fernandes Felix, Rodrigo Pessoa Cavalcanti Lira, Alexandre Brito Cosimo, Rodrigo Lourenço Cardeal da Costa, Maurício Abujamra Nascimento, Carlos Eduardo Leite Arieta

American Journal of Ophthalmology

Three-year Follow-upOcular DiseaseEye HealthPharmacotherapyToxoplasmic Retinochoroiditis RecurrencesDermatologyMedicineTrimethoprim-sulfamethoxazole Versus Placebo

References

	Year	Citations

Page 1